Industries > Pharma > Global Stem Cell Technologies and Applications Market 2017-2027

Global Stem Cell Technologies and Applications Market 2017-2027

Cancer, Cardiovascular, CNS, Other Disease Areas and Non-Therapeutic Applications

PUBLISHED: 06 March 2017
PAGES: 261
PRODUCT CODE: PHA0173

Clear
WOOCS 2.2.1

The global stem cell technologies and applications market is expected to grow at a CAGR of 13.4% in the first half of the forecast period and CAGR of 10.5% in the second half of the forecast period. The market is expected to grow at a CAGR of 11.7% from 2016 to 2027. The market is estimated at $10,751 million in 2016 and $17,768 million in 2020.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 257-page report you will receive 114 charts – all unavailable elsewhere.

The 257-page report provides clear detailed insight into the global stem cell technologies and applications market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Stem Cell Technologies and Applications Market 2017-2027

Report Scope
• Global Stem Cell Technologies and Applications Market forecasts
from 2017-2027

• Global Stem Cell Technologies and Applications submarket forecasts from 2017-2027:
– Cancer treatment
– Cardiovascular therapy
– CNS
– Other therapies
– Non-therapeutic applications

• Individual revenue forecast to 2027 for selected top products:
– MSC-100-IV (Mesoblast)
– Hearticellgram-AMI (Pharmicell)
– CardioRel (Reliance Life Sciences)
– Osteocel Plus (NuVasive)
– Trinity Evolution and Elite (Orthofix)
– CARTISTEM (MEDIPOST)

• Analysis of the most promising pipeline therapies in each therapeutic segment

• Discussion on regulatory environments and developments in the US, Japan, Europe and other leading countries

• Analysis of what drives and restrains the market

• This study also discusses other influences on that field, including these:
– Haematopoietic stem cell transplantation (HSCT)
– Embryonic stem cells (ESCs), induced pluripotent adult (IPSCs) and parthenogenetic cells
– Uses for umbilical cord blood and related technologies, including cellular and blood banking
– Agents for osteogenesis and treating autoimmune conditions
– Applications in cell-based assays, diagnostics and drug development.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Stem Cell Technologies and Applications Market. You find data, trends and predictions.

Buy our report today Global Stem Cell Technologies and Applications Market 2017-2027: Cancer, Cardiovascular, CNS, Other Disease Areas and Non-Therapeutic Applications.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Stem Cell Technologies and Applications Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Stem Cell Technologies and Applications Market 2017-2027


Latest Pharma news

Visiongain Publishes Biopharmaceuticals Contract Manufacturing Market Report 2022-2032

Ageing population will be more susceptible to such diseases and is one of the key factors driving the growth of the global biological drugs market. In most of the developed world, the share of elderly population is almost touching a quarter of the population.

26 January 2022

READ

Visiongain Publishes Topical Drug Delivery Market Report 2022-2032

Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of burn incidences and the growing prevalence of diabetes.

26 January 2022

READ

Visiongain Publishes Decentralized Clinical Trials Market Report 2022-2032

The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.

24 January 2022

READ

Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022

READ

Categories